ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer
Published online: 17 December 2024 - ESMO Open
Vogel A & Ducreux M, on behalf of the ESMO Guidelines Committee
- This ESMO Clinical Practice Guideline update addresses new developments in the management of biliary tract cancer.
- Recommendations are given for first-line treatment with immune checkpoint inhibitors.
- Key recommendations are also provided for second-line treatment with targeted therapies.
- The update also covers the latest developments in molecular testing and intra-arterial therapies.
- A management algorithm for early-stage, locally advanced and advanced/metastatic disease is provided.